Vinpocetine

Vinpocetine is a periwinkle plant extract (Vinca major) that improves brain function. It has been used medicinally in Europe since 1983.

Vinpocetine dilates the arteries of the brain, decreases platelate aggregation, and increases erythrocyte flexibility, all of which are beneficial in cerebrovascular disease.  By increasing the brain's
utilization of oxygen and oxygen, vinpocetine increases cerebral metabolic rate.

Vinpocetine can help prevent stroke and can prevent much of the damage that occurs following stroke if administered immediately following stroke.

     
                     
vinpocetine article                
Vinpocetine:

  • dilates the arteries of the brain but does not dilate other blood vessels

  • improves the brain's utilization of oxygen

  • improves the brain's utilization of glucose

  • accelerates the rate of learning in animal studies by up to 40%.

  • increases the length of time that short-term memory is retained.  

  • improves circulation to the eyes thereby improving vision and eyesight disorders.

  • improves impaired hearing and improves inner-ear problems.

  • improves tinnitus (ringing in the ears) and vertigo (dizziness).

  • can prevent stroke and mitigate damage in the aftermath of stroke.

  • can block the action of drugs that disrupt memory.

  • improved the vertigo (dizziness) of 77% of the patients in one study.

  • improves the flexibility of red blood cells and may thereby help to prevent strokes.

References

References

  Kiss B, Karpati E, Mechanism of action of vinpocetine, Acta Pharm Hung 1996 Sep;66(5):213-24

  Szakall S, et al. Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study. J Neuroimaging 1998 Oct;8(4):197-204

  Feigin VL, et al. Vinpocetine treatment in acute ischaemic stroke a pilot single-blind randomized clinical trial. Eur J Neurol. 2001 Jan;8(1)81-5.

  Bonoczk P, et al, Role of sodium channel inhibition in neuroprotection: effect of vinpocetine. Brain Res Bull 2000 Oct;53(3):245-54.

  Meyer, E. D., et al. Pilot study about the application of Vinpocetine  in ENT. Z Klin Med. 4051-54, 1985.

  Pliushko, D. G., et al. Drug therapy of initial open-angle glaucoma. Oftalmol Zh. 272.74, 1989.

  Brooder, G., et al. Preliminary report on the use of Vinpocetine in affections of the eyeground. Arzneimittelforschung. 261973-1975, 1976.

  Kahan, A., et al. Use of ethyl Vinpocetine  in ophthalmological therapy. Arzneimittelforschung . 26(10a)1969-1972, 1976.

  Olah, V. A., et al. An in vitro study of the hydroxyl scavenger effect of Vinpocetine. Acta Paediatr Hung. 30(2)309-316, 1990.

            

 BRAIN PRODUCTS

Order  Aniracetam 750 mg 30 caps 22.99
Order  CDP-Choline 200 mg 60 caps 19.99
Order  Centrophenoxine 250 mg 60 caps 19.99
Order  Deprenyl 5 mg 50 tabs 60.00
Order  DMAE 125 mg 100 caps 5.99
Order  Galantamine   8 mg 30 caps 23.99
Order  Huperzine A 100 mcg 60 caps 9.99
Order  Phosphatidylserine    6 bottles @ $18 = $108 100 mg 60 caps 29.99
Order  Picamilon                      4 bottles @ $24 = $96 100 mg 60 caps 29.99
Order  Piracetam 800 mg 60 caps 14.99
Order  Pyritinol 200 mg 60 caps 14.99
Order  Vinpocetine                  6 bottles @ $12 = $72 20 mg 60 caps 19.99
Order  Get SmartTM              as reported in Wired magazine 815 mg 60 caps 38.99

        ingredients in 2 capsules
Aniracetam 800 mg

   more potent analog of piracetam

Centrophenoxine 300 mg    raises brain acetylcholine levels
Pyritinol 300 mg    improves memory, concentration
Picamilon 100 mg    increases circulation to the brain
Piracetam 100 mg    increases communication between the 2 hemispheres of the brain
Oxiracetam 10 mg    more potent analog of piracetam
Vinpocetine 10 mg    dilates blood vessels in the brain
Idebenone 10 mg    increases nerve growth factor (NGF) in the brain
Huperzine A 100 mcg    extends the life of acetylcholine in the brain


Smart Nutrition
1765 Garnet Ave # 66
San Diego, CA 92109
phone: 858-270-7907
smart@smartnutrition.info